BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 32776434)

  • 1. Successful treatment of hepatosplenic T cell lymphoma in an adolescent with Turner syndrome using ifosfamide, carboplatin, and etoposide followed by allogeneic hematopoietic stem cell transplant.
    Lauhan CR; Schiff D; Gloude N
    Pediatr Blood Cancer; 2020 Nov; 67(11):e28528. PubMed ID: 32776434
    [No Abstract]   [Full Text] [Related]  

  • 2. Intensive induction chemotherapy followed by early high-dose therapy and hematopoietic stem cell transplantation results in improved outcome for patients with hepatosplenic T-cell lymphoma: a single institution experience.
    Voss MH; Lunning MA; Maragulia JC; Papadopoulos EB; Goldberg J; Zelenetz AD; Horwitz SM
    Clin Lymphoma Myeloma Leuk; 2013 Feb; 13(1):8-14. PubMed ID: 23107915
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hepatosplenic γδ T-cell lymphoma of two adolescents: Case report and retrospective literature review in children, adolescents, and young adults.
    McThenia SS; Rawwas J; Oliveira JL; Khan SP; Rodriguez V
    Pediatr Transplant; 2018 Aug; 22(5):e13213. PubMed ID: 29921021
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepatosplenic alphabeta T cell lymphoma.
    Nagai Y; Ikegame K; Mori M; Inoue D; Kimura T; Shimoji S; Togami K; Tabata S; Kurata M; Imai Y; Matsushita A; Nagai K; Ogawa H; Takahashi T
    Int J Clin Oncol; 2010 Apr; 15(2):215-9. PubMed ID: 20217452
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relapsed subcutaneous panniculitis-like T cell lymphoma: role of haploidentical hematopoietic stem cell transplant.
    Dholaria B; Patel RJ; Sluzevich JC; Ailawadhi S; Roy V
    Ann Hematol; 2017 Dec; 96(12):2125-2126. PubMed ID: 28879427
    [No Abstract]   [Full Text] [Related]  

  • 6. Successful Bridging Chemotherapy with Gemcitabine, Carboplatin, and Dexamethasone before Unrelated Stem Cell Transplantation for Hepatosplenic T-cell Lymphoma.
    Okuni M; Yakushijin K; Uehara K; Ichikawa H; Suto H; Hashimoto A; Tanaka Y; Shinzato I; Sakai R; Mizutani Y; Nagao S; Kurata K; Kakiuchi S; Miyata Y; Inui Y; Saito Y; Kawamoto S; Yamamoto K; Ito M; Matsuoka H; Minami H
    Intern Med; 2019 Mar; 58(5):707-712. PubMed ID: 30449784
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sustained first remission in an adolescent with hepatosplenic T-cell lymphoma treated with T-cell leukemia induction, nucleoside analog-based consolidation, and early hematopoietic stem cell transplant.
    Schafer E; Chen A; Arceci RJ
    Pediatr Blood Cancer; 2009 Dec; 53(6):1127-9. PubMed ID: 19479793
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Allogeneic transplantation for hepatosplenic alphabeta T-cell lymphoma.
    Mansour MR; Dogan A; Morris EC; Khwaja A; Linch DC; Mackinnon S; Peggs KS
    Bone Marrow Transplant; 2005 May; 35(9):931-4. PubMed ID: 15778731
    [No Abstract]   [Full Text] [Related]  

  • 9. Successful treatment with reduced-intensity cord blood transplant in a patient with relapsed refractory hepatosplenic T-cell lymphoma.
    Sumi M; Takeda W; Kaiume H; Kirihara T; Kurihara T; Sato K; Ueki T; Hiroshima Y; Ueno M; Ichikawa N; Kobayashi H
    Leuk Lymphoma; 2015 Apr; 56(4):1140-2. PubMed ID: 25065703
    [No Abstract]   [Full Text] [Related]  

  • 10. Hepatosplenic γ-δ T-Cell Lymphoma: Who Is on Your Speed Dial?
    Krishnan M; Lunning M
    J Oncol Pract; 2019 Jun; 15(6):307-312. PubMed ID: 31185190
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A rare cause of Fever, hepatosplenomegaly, and thrombocytopenia: hepatosplenic gamma/delta T-cell lymphoma.
    Albayrak M; Balcik OS; Alan S; Dıncer SL; Yüksel MK; Albayrak A
    Pathol Oncol Res; 2011 Jun; 17(2):421-3. PubMed ID: 21197592
    [No Abstract]   [Full Text] [Related]  

  • 12. Phase I study of high-dose ifosfamide, carboplatin and etoposide with autologous hematopoietic stem cell support.
    Lotz JP; Izrael V
    Bone Marrow Transplant; 1995 Dec; 16(6):858-9. PubMed ID: 8750286
    [No Abstract]   [Full Text] [Related]  

  • 13. High-dose chemotherapy with carboplatin, etoposide and ifosfamide followed by autologous stem cell rescue in patients with relapsed or refractory malignant lymphomas: a phase I/II study.
    Kleiner S; Kirsch A; Schwaner I; Kingreen D; Schwella N; Huhn D; Siegert W
    Bone Marrow Transplant; 1997 Dec; 20(11):953-9. PubMed ID: 9422474
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A case of hepatosplenic T-cell lymphoma successfully treated by HLA haploidentical stem cell transplantation.
    Iwaki N; Mochizuki K; Ozaki J; Maeda Y; Kurokawa T
    J Clin Exp Hematop; 2020 Jun; 60(2):55-59. PubMed ID: 32404572
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dyspoietic changes associated with hepatosplenic T-cell lymphoma are not a manifestation of a myelodysplastic syndrome: analysis of 25 patients.
    Yabe M; Medeiros LJ; Tang G; Wang SA; P Patel K; Routbort M; Bhagat G; Bueso-Ramos CE; Jorgensen JL; Luthra R; Chen W; Muzzafar T; Kanagal-Shamanna R; Khoury JD; Daneshbod Y; Davanlou M; Li S; Young KH; Miranda RN
    Hum Pathol; 2016 Apr; 50():109-17. PubMed ID: 26997444
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High-dose treatment with carboplatin, etoposide, and ifosfamide followed by autologous stem-cell transplantation in relapsed or refractory germ cell cancer: a phase I/II study. The German Testicular Cancer Cooperative Study Group.
    Siegert W; Beyer J; Strohscheer I; Baurmann H; Oettle H; Zingsem J; Zimmermann R; Bokemeyer C; Schmoll HJ; Huhn D
    J Clin Oncol; 1994 Jun; 12(6):1223-31. PubMed ID: 7911158
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical features and treatment outcomes of 14 patients with hepatosplenic γ δ T-cell lymphoma.
    Wang Q; Jiang Y; Zhu Q; Duan Y; Chen X; Xu T; Jin Z; Li C; Wu D; Huang H
    J Cancer Res Clin Oncol; 2021 Nov; 147(11):3441-3445. PubMed ID: 33856526
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of relapsed aggressive lymphomas: regimens with and without high-dose therapy and stem cell rescue.
    Hagemeister FB
    Cancer Chemother Pharmacol; 2002 May; 49 Suppl 1():S13-20. PubMed ID: 12042984
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of germ cell cancer with two cycles of high-dose ifosfamide, carboplatin, and etoposide with autologous stem-cell support.
    Margolin K; Doroshow JH; Ahn C; Hamasaki V; Leong L; Morgan R; Raschko J; Shibata S; Somlo G; Tetef M
    J Clin Oncol; 1996 Oct; 14(10):2631-7. PubMed ID: 8874321
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hepatosplenic gamma-delta T-cell lymphoma.
    Ferreri AJ; Govi S; Pileri SA
    Crit Rev Oncol Hematol; 2012 Aug; 83(2):283-92. PubMed ID: 22047938
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.